Dec 31 2024 18 mins 1
In this episode of NETCAST, leading neuroendocrine experts Dr. Mohammed and Dr. Chauhan meet with Dr. Gangi to discuss their recent studies on innovative therapies for neuroendocrine tumors. Dr. Chauhan presents findings on Peltocetine, a new oral somatostatin receptor agonist, highlighting its efficacy in treating carcinoid syndrome. Dr. Mohammed shares insights on NP101, a combination therapy for metastatic neuroendocrine carcinomas, emphasizing its potential in enhancing treatment outcomes. The conversation explores the future of neuroendocrine cancer treatment, focusing on patient preferences and the importance of ongoing research.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
